- Home
- SNY vs SIGIP Comparison
SNY vs SIGIP Comparison
Compare SNY & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- SIGIP
- Stock Information
- Founded
- SNY 1994
- SIGIP N/A
- Country
- SNY France
- SIGIP United States
- Employees
- SNY N/A
- SIGIP 2800
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- SIGIP Property-Casualty Insurers
- Sector
- SNY Health Care
- SIGIP Finance
- Exchange
- SNY Nasdaq
- SIGIP Nasdaq
- Market Cap
- SNY 116.5B
- SIGIP N/A
- IPO Year
- SNY N/A
- SIGIP N/A
- Fundamental
- Price
- SNY $48.32
- SIGIP $16.91
- Analyst Decision
- SNY Buy
- SIGIP
- Analyst Count
- SNY 2
- SIGIP 0
- Target Price
- SNY $62.50
- SIGIP N/A
- AVG Volume (30 Days)
- SNY 2.1M
- SIGIP N/A
- Earning Date
- SNY 07-24-2025
- SIGIP N/A
- Dividend Yield
- SNY 3.31%
- SIGIP N/A
- EPS Growth
- SNY 39.56
- SIGIP N/A
- EPS
- SNY 5.45
- SIGIP N/A
- Revenue
- SNY $48,817,552,946.00
- SIGIP N/A
- Revenue This Year
- SNY $3.39
- SIGIP N/A
- Revenue Next Year
- SNY $7.05
- SIGIP N/A
- P/E Ratio
- SNY $8.86
- SIGIP N/A
- Revenue Growth
- SNY N/A
- SIGIP N/A
- 52 Week Low
- SNY $45.80
- SIGIP N/A
- 52 Week High
- SNY $60.12
- SIGIP N/A
- Technical
- Relative Strength Index (RSI)
- SNY 43.46
- SIGIP 50.19
- Support Level
- SNY $47.64
- SIGIP $16.61
- Resistance Level
- SNY $49.37
- SIGIP $17.00
- Average True Range (ATR)
- SNY 0.64
- SIGIP 0.14
- MACD
- SNY 0.13
- SIGIP 0.03
- Stochastic Oscillator
- SNY 32.61
- SIGIP 62.50
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.